The present invention relates to a multilayered wound dressing particularly for wound treatment in the granulation and epithelization phase. The wound dressing comprises a) a first layer as a wound contact layer having a first side and a second side, and b) at least one second layer as an absorbent layer having a first side and a second side and comprising a hydrophilic polyurethane foam, wherein the polyurethane foam comprises a water fraction of at least 10% by weight of water.

A system for wound treatment using a serum, comprising a device for recovering serum from whole blood, comprising: a blood bag for the reception and coagulation of whole blood, which has an outlet for discharging the serum-containing fluid from the blood bag and a barrier in the region of the outlet for retaining the coagulum, a filter module which is fluidically connected to the blood bag and comprises a housing and an interior, in which a semi-permeable membrane is arranged, said membrane dividing the interior into a retentate space and a permeate space and separating the fluid discharged from the blood bag into a permeate comprising the serum and into a retentate in which any particulate components contained in the fluid remain.

The system for wound treatment further comprises a wound care system with a capillary membrane system for dispensing the serum to a wound. The capillary membrane system is connected to at least one supply line, which for its part is connected to the permeate outlet of the filter module.

Wound dressings and wound inserts comprising substantially dry reactive agents, methods of forming wound inserts comprising dry reactive agents, and wound-treatment methods.

Examples include devices, systems and methods related to advanced wound therapy dressings. Specific examples are optimized for use with mobile continuous diffusion of oxygen therapy systems for the localized delivery of oxygen to damaged and healing tissues. Examples may utilize a conduit to deliver therapeutic fluids, including for example oxygen, where the conduit comprises a plurality of apertures or perforations. Examples may also include a spacer material with a plurality of distribution channels in fluid communication with the conduit.

An article for therapy and treatment of at least one eye. The article includes a backing for application to the at least one eye. The backing includes at least one receiver positioned to align with the at least one eye. The article also includes at least one pod that is detachably secured within the at least one receiver. The at least one pod includes material for delivering therapy and treatment to the at least one eye.

The present disclosure provides sulfhydryl-modified polymer foams, which may be used for wound dressing materials. For example, the modified materials can include free sulfhydryl group, which can serve as a linker to attach biologically active molecules. For example, sulfhydryl groups can be used to conjugate biologically active polypeptides and/or metals to foam polymers. Methods for using sulfhydryl-modified polymers, such as for wound dressings, are also provided.

A wound care device for delivering topical oxygen therapy and negative pressure wound therapy for treatment of a wound. The wound care device may include an oxygen supply membrane electrode device (MEA), a vacuum pump and motor, a pressure sensor, and a power supply and electronic controls. A dressing may be connected to the wound care device for administering topical continuous oxygen therapy and negative pressure wound therapy to a wound. The wound care device may be operated to provide simultaneous topical oxygen therapy and negative pressure wound therapy, continuous oxygen therapy with intermittent negative pressure wound therapy, and alternating oxygen therapy and negative pressure wound therapy.

A treatment system for applying negative pressure therapy and fluid instillation treatment to a tissue site, particularly an abdominal tissue site, is disclosed. In some embodiments, the treatment system may include a dressing member, a plurality of fluid removal pathways, a fluid instillation matrix, a drape, a negative-pressure source, and a fluid instillation source. Instillation fluid may be delivered from the fluid instillation source to the tissue site through the fluid instillation matrix, and negative pressure may be communicated and fluid withdrawn from the tissue site through the plurality of fluid removal pathways.

Systems and methods can promote wound healing, including a wound dressing having a wound-facing surface and a second surface. The wound-facing surface can be configured to contact a wound of a patient. There can also be at least one conduit having an interior lumen operably connectable to the second surface of the wound dressing, a central window configured to allow air flow from the interior lumen of the conduit to the wound-facing surface of the wound dressing, and a flexible wrap operably connectable to the conduit.

A surgical or wound closure device utilizes a slide fastener for rapidly closing a surgical incision or wound with precise apposition of the sides of the incision. The surgical closure devices are configured for linear incisions, shaped incisions, such as used for wedge biopsy or excisional biopsy, and long incisions, such as used for laparotomy or surgical removal of redundant skin. The surgical closure device may be adhered to the patient's skin prior to making an incision and is subsequently used for closing the incision.